High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031)
about
Energy metabolism in neurodevelopment and medulloblastomaManagement of pediatric and adult patients with medulloblastoma.Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potentialChallenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in MalaysiaOvercoming multiple drug resistance mechanisms in medulloblastoma.Medulloblastoma subgroups remain stable across primary and metastatic compartments.Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity?Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma.Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.Managing teenage/young adult (TYA) brain tumors: a UK perspective.Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cells.Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's OncoloMedulloblastoma: Molecular Classification-Based Personal Therapeutics.Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).Adjuvant chemotherapy and overall survival in adult medulloblastoma.Long-term life expectancy for children with ependymoma and medulloblastoma.The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance ChemOutcomes and patterns of care in a nationwide cohort of pediatric medulloblastoma: Factors affecting proton therapy utilization.Geminin deficiency enhances survival in a murine medulloblastoma model by inducing apoptosis of preneoplastic granule neuron precursors.Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?[The chemotherapy before or after radiation therapy does not influence survival of children with high-risk medulloblastomas: results of the multicenter and randomized study of the Pediatric Oncology Group (POG 9031)].Early detection of recurrent medulloblastoma: the critical role of diffusion-weighted imaging
P2860
Q26770345-92037C83-43B5-4596-BB4D-1C1C7F84DA4BQ30847947-996E7E4E-0A07-451F-A86F-A0E9A59EF0A1Q33618570-29BF8511-AE73-4AA8-82E2-E1FA317BC951Q33859754-951BC5CA-0C7B-4102-A3A5-CB91F47242E5Q34500602-62A4EA1F-062D-4768-B8B1-15E9D2DDD2D6Q35099027-E3D748BD-E250-4EFD-9E1A-57ABA8202EE8Q35192360-6E2A5FA2-E9DA-43A7-9C2D-EA845F879FE8Q35754390-797BE08B-4271-4690-A662-CDC72D657C92Q36106864-DA1EC44C-40E2-40D4-B5E3-EA782E1FDB9FQ36493799-F7BB0FAC-9C1F-462C-A0C9-B6C839A6F158Q36901551-0D31CFA7-2117-4341-BCCD-5D39D5B62EC1Q37004219-47896C0D-123C-4674-91FC-6D74B5F9DC34Q37323400-3AA840B6-12DC-4409-8266-7C20F531661EQ37636027-D7FA141D-22A2-4932-A559-E85DF1C1C422Q38539466-4D85B646-BB2E-4E9D-B269-E51B8153964EQ38791824-D8A43749-A71E-4CD8-8FB5-B7F92100B0C7Q38806100-AF146D3C-3771-43D3-A6B4-B64B91F98FC4Q38836198-05F8847F-56D5-4771-AFEC-694ED9E5761FQ38889086-DE9A50F1-6BC2-4137-84CA-865AFE9007E5Q39078623-09B9FB26-A0A4-46B9-8223-8CEDC0E61D20Q39225738-2D60D796-5582-40A1-BFB9-7C39DC7BF4F3Q39382354-14A7A85E-1528-4CE5-8C08-9822F171E958Q39475097-0B66AE0B-5CEB-4D97-9691-FEC9C0D91AA5Q40897111-35CC1791-F790-44EF-929D-A62BCA69668FQ41482342-048681D6-DD2D-4B0C-B02C-413A3FB1D3DFQ47113903-D67E6EE4-BE26-4CFD-B8F7-E8406A5D1F14Q47115561-71EA0F7C-4831-45B6-A615-64FD174AE36FQ47363064-C9164D50-5D72-431A-8F1A-E0884F53EC39Q47827397-0F8A19F3-70EB-4938-B724-BBE40F039D10Q55459492-1E60C963-9DEA-403E-B1BA-28D97BD833B8Q55461345-D3496CBC-7244-42AA-AE9E-CC5B2DD02574Q58571041-1ABF773D-D7B8-4F6C-8217-862AAECB2698
P2860
High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High-risk medulloblastoma: a p ...... r radiation therapy (POG 9031)
@en
High-risk medulloblastoma: a p ...... ore or after radiation therapy
@nl
type
label
High-risk medulloblastoma: a p ...... r radiation therapy (POG 9031)
@en
High-risk medulloblastoma: a p ...... ore or after radiation therapy
@nl
prefLabel
High-risk medulloblastoma: a p ...... r radiation therapy (POG 9031)
@en
High-risk medulloblastoma: a p ...... ore or after radiation therapy
@nl
P2093
P2860
P921
P356
P1476
High-risk medulloblastoma: a p ...... r radiation therapy (POG 9031)
@en
P2093
Nancy J Tarbell
Patrick Barnes
Peter Burger
Tianni Zhou
Torunn Yock
William R Polkinghorn
Zhengjia Chen
P2860
P304
P356
10.1200/JCO.2012.43.9984
P407
P577
2013-07-15T00:00:00Z